Search Results for:
-
INTEREST MUSHROOMS IN TAXOL FROM FUNGUS
That's my ultimate dream," Stierle told BioWorld. -- David N. Leff Science Editor (c) 1997 American Health ConsultantsBioWorld Today | Friday, April 9, 1993 -
NIH LICENSING AIDS DRUGS
By substituting a halogen atom (chlorine or iodine) for an oxygen, one "confers substantial lipophilicity on these new analogs, but they appear to exert their anti-viral activity only upon conversion to ddI or ddG (dideoxyguanosine)." -- David N. Leff Science Editor (c) 1997 American Health ConsultantsBioWorld Today | Thursday, April 8, 1993 -
MUTANT CF GENE CAN'T GET THERE
We're exploring that avenue here at Genzyme, too, but it's not our main focus." -- David N. Leff Science Editor (c) 1997 American Health ConsultantsBioWorld Today | Friday, April 2, 1993 -
NIH LICENSING PLATELET GF GENE TO COR
Cor's stock (NASDAQ:CORR) closed unchanged Friday at $9.50 a share. -- David N. Leff Science Editor (c) 1997 American Health ConsultantsBioWorld Today | Monday, March 29, 1993 -
THERAPEUTIC GLIAL GROWTH FACTOR
For the latter, you wouldn't want to induce proliferation, which can have deleterious effects of cellular overgrowth." -- David N. Leff Science Editor (c) 1997 American Health ConsultantsBioWorld Today | Thursday, March 25, 1993 -
ZENECA, CROP TAKE ON CORN BORER
of Cambridge, Mass., and Xoma Corp.., Berkeley, Calif., are among the leaders in ricin immunotoxins for cancer therapy. -- David N. Leff Science Editor (c) 1997 American Health ConsultantsBioWorld Today | Friday, March 5, 1993 -
BLUE GENES ARE BACK IN STYLE
5,077,201, which lists 18 claims for the use of a mutated fungal culture to produce indigo. -- David N. Leff Science Editor (c) 1997 American Health ConsultantsBioWorld Today | Monday, March 1, 1993 -
ICI SPLITS OFF BIOSCIENCE OPERATIONS
In the pharmaceutical field, disclosures concern diagnosis and therapy of Alzheimer's disease, plasmin-inhibiting antibodies and ricin toxin chains for monoclonal-conjugation, and multifunction expression vectors. -- David N. Leff Science Editor (c) 1997 American Health ConsultantsBioWorld Today | Friday, February 26, 1993 -
PAY ABUSE NOT A FACTOR IN BIOTECH
for more than 100 staffers, $207,300. -- Likewise, the team of top managers grows with company size, from a lean head count of four team players -- CEO, chief financial officer, vice president of research and development, VP of operations -- in a company with 25 or fewer employees, to double that number -- adding VPs for sales and marketing, regulatory affairs, human resources and business development -- for one with 100 or more people on staff. -- David N. Leff Science Editor (c) 1997BioWorld Today | Thursday, February 25, 1993 -
RESEARCHERS TRY TO GROW FETAL CELLS
So far, all we really know about them is that they grow in a dish." -- David N. Leff Science Editor (c) 1997 American Health ConsultantsBioWorld Today | Wednesday, February 24, 1993 -
SKB ADDS $20 MILLION TO STAKE IN IDEC
Pan-Bs, Krawiec explained, target and bind to a B-cell surface marker present on the tumors of more than 90 percent of all lymphoma patients. -- David N. Leff Science Editor (c) 1997 American Health ConsultantsBioWorld Today | Tuesday, February 23, 1993 -
AFRICAN SWEET POTATOES TAUGHT TO FIGHT VIRUS
It doesn't require special machines or additional know-how because the technology will be contained in the seed." -- David N. Leff Science Editor (c) 1997 American Health ConsultantsBioWorld Today | Monday, February 22, 1993 -
DIATECH SET TO SLEUTH CHOLESTEROL
subsidiary of a large French company, Ipsen-Beaufour of Paris, which has a $600 million turnover in therapeutic drugs "If we select their peptide," said Dean, "by the mid-1990s, we can look forward to product copromotion by both our sales forces of their therapeutic and our imaging agent." -- David N. Leff Science Editor (c) 1997 American Health ConsultantsBioWorld Today | Wednesday, February 17, 1993 -
DICTYOSTELIUM AMOEBAE MIGHT MANUFACTURE DRUGS
it's a haploid eukaryote, and can be treated in an industrial manner." -- David N. Leff Science Editor (c) 1997 American Health ConsultantsBioWorld Today | Friday, February 12, 1993 -
CELL MESSAGE MUTATION CAUSES RARE IMMUNE DISEASE
It will certainly be worth watching for the next year or two." -- David N. Leff Science Editor (c) 1997 American Health ConsultantsBioWorld Today | Thursday, February 11, 1993 -
SMOKING OUT P53'S ROLE IN TOBACCO-RELATED CANCER
020393P53 -- David N. Leff Science Editor (c) 1997 American Health ConsultantsBioWorld Today | Wednesday, February 3, 1993 -
DRUG CUTS POST-SURGERY INFECTION RATE
Alpha-Beta's stock closed unchanged on Friday at $21 a share. -- David N. Leff Science Editor (c) 1997 American Health ConsultantsBioWorld Today | Monday, February 1, 1993 -
JOB-SEEKERS FLOOD EMPLOYMENT FAIR
She suggests that "current hiring efforts are a clear indicator of the growth orientation of this industry." -- David N. Leff Science Editor (c) 1997 American Health ConsultantsBioWorld Today | Thursday, January 28, 1993 -
DRUG TAILOR-MADE FOR COMMON COLD
His company is actively pursuing its anti-viral program, Kelley added, but "does not at present have any compounds in preclinical development." -- David N. Leff Science Editor (c) 1997 American Health ConsultantsBioWorld Today | Wednesday, January 27, 1993 -
RECOMBINANT ANTI-TUMOR TOXIN
Pastan foresees the single-chain toxin conjugate as being used primarily to scavenge residual metastatic cells of many tumor types, once the main bulk of a solid tumor has been surgically removed. -- David N. Leff Science Editor (c) 1997 American Health ConsultantsBioWorld Today | Thursday, January 21, 1993
Category
Current Filters
- xScience Editor
Related Keywords
Categories
- x BioWorld Today (3419)
- x Bio Perspectives (156)
- x BioWorld Insight (18)
- x BioWorld International (16)
- x State of the Industry Report (12)
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5476
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5476
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.